| Secondary |
| Parkinson's Disease |
38.5% |
| Drug Use For Unknown Indication |
18.2% |
| Product Used For Unknown Indication |
12.5% |
| Hypertension |
6.3% |
| Fibromyalgia |
2.6% |
| Infection |
2.6% |
| Diabetes Mellitus |
2.1% |
| Abnormal Behaviour |
1.6% |
| Agitation |
1.6% |
| Dementia |
1.6% |
| Depression |
1.6% |
| Epilepsy |
1.6% |
| Hypersomnia |
1.6% |
| Influenza Immunisation |
1.6% |
| Anaemia |
1.0% |
| General Physical Health Deterioration |
1.0% |
| Insomnia |
1.0% |
| Irritable Bowel Syndrome |
1.0% |
| Mania |
1.0% |
| Pain |
1.0% |
|
| Pathological Gambling |
14.3% |
| Urinary Tract Infection |
10.2% |
| Fall |
8.2% |
| Sudden Death |
8.2% |
| Weight Decreased |
8.2% |
| Impulse-control Disorder |
6.1% |
| Stereotypy |
6.1% |
| Abnormal Behaviour |
4.1% |
| Hypotonia |
4.1% |
| Psychomotor Retardation |
4.1% |
| Psychotic Disorder |
4.1% |
| Tachycardia |
4.1% |
| Tubulointerstitial Nephritis |
4.1% |
| Completed Suicide |
2.0% |
| Cytolytic Hepatitis |
2.0% |
| Extrapyramidal Disorder |
2.0% |
| Haemolytic Anaemia |
2.0% |
| Hyponatraemia |
2.0% |
| Impaired Self-care |
2.0% |
| Interstitial Lung Disease |
2.0% |
|
| Concomitant |
| Parkinson's Disease |
26.7% |
| Drug Use For Unknown Indication |
15.5% |
| Product Used For Unknown Indication |
12.4% |
| Hypertension |
6.2% |
| B-cell Lymphoma |
3.4% |
| Diabetes Mellitus |
3.4% |
| Hepatitis C |
3.4% |
| Depression |
3.1% |
| Pruritus |
3.1% |
| Rheumatoid Arthritis |
3.1% |
| Glaucoma |
2.8% |
| Burkitt's Lymphoma |
2.6% |
| Osteoporosis |
2.3% |
| Chronic Hepatitis C |
1.8% |
| Chronic Obstructive Pulmonary Disease |
1.8% |
| Convulsion |
1.8% |
| Essential Hypertension |
1.8% |
| Affective Disorder |
1.6% |
| Anaemia |
1.6% |
| Anxiety |
1.6% |
|
| Vomiting |
11.8% |
| Weight Decreased |
9.4% |
| Status Epilepticus |
7.1% |
| Tremor |
5.9% |
| Dyskinesia |
4.7% |
| Hallucination |
4.7% |
| Hyponatraemia |
4.7% |
| Malaise |
4.7% |
| Ocular Hypertension |
4.7% |
| Paralysis |
4.7% |
| Renal Failure Acute |
4.7% |
| Thrombocytopenia |
4.7% |
| Anaemia Haemolytic Autoimmune |
3.5% |
| Dyspnoea |
3.5% |
| Gamma-glutamyltransferase Increased |
3.5% |
| Myoglobin Blood Increased |
3.5% |
| Porphyria Non-acute |
3.5% |
| Prothrombin Time Prolonged |
3.5% |
| Rhinalgia |
3.5% |
| Somnolence |
3.5% |
|
| Interacting |
| Drug Use For Unknown Indication |
100.0% |
|
|
